Cita APA

Kramer, C., Yaniz-Galende, E., Pellegrino, B., ter Haar, N., Llop-Guevara, A., Herencia Ropero, A., & Serra, V. (2023). RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: Robustness and interobserver variability of the RAD51 test.

Citación estilo Chicago

Kramer, Claire, Elisa Yaniz-Galende, Benedetta Pellegrino, Natalja ter Haar, Alba Llop-Guevara, Andrea Herencia Ropero, y Violeta Serra. RAD51 As a Biomarker for Homologous Recombination Deficiency in High-grade Serous Ovarian Carcinoma: Robustness and Interobserver Variability of the RAD51 Test. 2023.

Cita MLA

Kramer, Claire, et al. RAD51 As a Biomarker for Homologous Recombination Deficiency in High-grade Serous Ovarian Carcinoma: Robustness and Interobserver Variability of the RAD51 Test. 2023.